Cancer immunotherapy involves strategies to harness and enhance the body's own immune system to fight cancer. This can include immune checkpoint inhibitors, [CAR T-cell therapy], cancer vaccines, and other approaches aimed at boosting the adaptive immune response. CAR T-cell therapy, for instance, involves engineering a patient's T cells to express receptors that specifically target cancer cells. These therapies have shown significant success in treating certain types of blood cancers and are being investigated for other malignancies.
